Vilex
-
Biologics
Royal Biologics Announces Partnership with Vilex to Distribute Their ALC Technology Portfolio for Expansion of Biologics in Lower Extremity Procedures
HACKENSACK, NJ, August 17, 2021 /OrthoSpineNews/ – Royal Biologics, an Autologous and Live Cellular solutions-focused company, and Vilex, a leader…
Read More » -
Extremities
Vilex Acquires DT MedTech and the Hintermann Series System™ Total Ankle Prostheses
MCMINNVILLE, Tenn., July 23, 2020 /PRNewswire/ — Vilex, LLC, a member of the Squadron Capital family of businesses, announced today that it has…
Read More » -
Financial
OrthoPediatrics Corp. Announces Divestiture of the Vilex Adult Business
WARSAW, Ind., Jan. 06, 2020 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of…
Read More » -
Extremities
OrthoPediatrics Announces Acquisition of Vilex and Novel External Fixation Technology
WARSAW, Ind., June 05, 2019 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company focused exclusively on advancing the field…
Read More »